Utility of the National Eye Institute VFQ-25 Questionnaire in a Heterogeneous Group of Multiple Sclerosis Patients

American Journal of Ophthalmology

Volumn 142, Issue 3, 2006, Pages 464-468

  Noble, Jason ^a   Forooghian, Farzin ^a,b   Sproule, Melanie ^a,b   Westall, Carol ^a,b   O'Connor, Paul ^c,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CATARACT; CLINICAL ARTICLE; CORRELATION COEFFICIENT; FEMALE; GLAUCOMA; HUMAN; MALE; MULTIPLE SCLEROSIS; OPHTHALMOLOGY; OPTIC NEURITIS; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RETINOPATHY; STUDENT T TEST; VISION; VISUAL FIELD; AGED; COMPARATIVE STUDY; CONTRAST SENSITIVITY; HEALTH CARE ORGANIZATION; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; SICKNESS IMPACT PROFILE; UNITED STATES; VISUAL ACUITY; VISUAL DISORDER;

ADULT; AGED; CONTRAST SENSITIVITY; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NATIONAL INSTITUTES OF HEALTH (U.S.); QUALITY OF LIFE; QUESTIONNAIRES; SICKNESS IMPACT PROFILE; UNITED STATES; VISION DISORDERS; VISUAL ACUITY; VISUAL FIELDS;

EID: 33748876619     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2006.04.051     Document Type: Article

References (18)

1. Warner J., and Lessell S. Neuro-ophthalmology of multiple sclerosis. Clin Neurosci 2 (1994) 180-188
2. Sorensen T.L., Frederiksen J.L., Bronnum-Hansen H., et al. Optic neuritis as onset manifestation of multiple sclerosis. a nationwide, long-term survey. Neurology 53 (1999) 473-478
3. Leibowitz U., and Alter M. Optic nerve involvement and diplopia as initial manifestations of multiple sclerosis. Acta Neurol Scand 44 (1968) 70-80
4. Chen L., and Gordon L.K. Ocular manifestations of multiple sclerosis. Curr Opin Ophthalmol 16 (2005) 315-320
5. Cole S.R., Beck R.W., Moke P.S., et al. The National Eye Institute Visual Function Questionnaire. experience of the ONTT Optic Neuritis Treatment Trial. Invest Ophthalmol Vis Sci 41 (2000) 1017-1021
6. Margolis M.K., Coyne K., Kennedy-Martin T., et al. Vision-specific instruments for the assessment of health-related quality of life and visual functioning. a literature review. Pharmacoeconomics 20 (2002) 791-812
7. Balcer L.J., Baier M.L., Kunkle A.M., et al. Self-reported visual dysfunction in multiple sclerosis. results from the 25-Item National Eye Institute Visual Function Questionnaire (VFQ-25). Mult Scler 6 (2000) 382-385
8. Ma S.L., Shea J.A., Galetta S.L., et al. Self-reported visual dysfunction in multiple sclerosis. new data from the VFQ-25 and development of an MS-specific vision questionnaire. Am J Ophthalmol 133 (2002) 686-692
9. Poser C.M., Paty D.W., Scheinberg L., et al. New diagnostic criteria for multiple sclerosis. guidelines for research protocols. Ann Neurol 33 (1983) 227-231
10. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis. an expanded disability status scale (EDSS). Neurology 33 (1983) 1444-1452
11. Mangione C.M., Lee P.P., Gutierrez P.R., et al., National Eye Institute Visual Function Questionnaire Field Test Investigators. Development of the 25-Item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol 119 (2001) 1050-1058
12. Mangione CM. The National Eye Institute 25-Item Visual Function Questionnaire Scoring Algorithm, Version 2000. Available at http://www.nei.nih.gov/resources. Accessed Date: March 27, 2006.
13. Mangione C.M., Lee P.P., Pitts J., et al., NEI-VFQ Field Test Investigators. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). Arch Ophthalmol 116 (1998) 1496-1504
14. Beck R.W., Gal R.L., Bhatti M.T., et al. Visual function more than 10 years after optic neuritis. experience of the optic neuritis treatment trial. Am J Ophthalmol 137 (2004) 77-83
15. Nordmann J.P., Saraux H., and Roullet E. Contrast sensitivity in multiple sclerosis. a study in 35 patients with and without optic neuritis. Ophthalmologica 195 (1987) 199-204
16. Sisto D., Trojano M., Vetrugno M., et al. Subclinical visual involvement in multiple sclerosis. a study by MRI, VEPs, frequency-doubling perimetry, standard perimetry, and contrast sensitivity. Invest Ophthalmol Vis Sci 46 (2005) 1264-1268
17. Jacobs L.D., Beck R.W., Simon J.H., et al., CHAMPS Study Group. Intramuscular interferon β-1a therapy initiated during a first demyelinating event in multiple sclerosis. N Engl J Med 343 (2000) 898-904
18. Liscic R.M., and Brecelj J. Visual evoked potentials in multiple sclerosis patients treated with interferon β-1a. Croat Med J 45 (2004) 323-327